These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23233575)

  • 1. Measuring bleeding as an outcome in clinical trials of prophylactic platelet transfusions.
    Bercovitz RS; O'Brien SH
    Hematology Am Soc Hematol Educ Program; 2012; 2012():157-60. PubMed ID: 23233575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New strategies for the optimal use of platelet transfusions.
    Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
    Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. POLYMORPHISM OF COLLECTION, TRANSFUSION AND EFFECTIVENESS OF DONOR PLATELETS CONCENTRATES.
    Gubanova MN; Ayupova RF; Zhiburt EB
    Anesteziol Reanimatol; 2017 Jan; 62(1):77-79. PubMed ID: 29932588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombocytopenia, bleeding, and use of platelet transfusions in sick neonates.
    Stanworth SJ
    Hematology Am Soc Hematol Educ Program; 2012; 2012():512-6. PubMed ID: 23233627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia.
    Vinholt PJ; Alnor A; Nybo M; Hvas AM
    Platelets; 2016 Sep; 27(6):547-54. PubMed ID: 27025360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic platelet transfusions: which dose is the best dose? A review of the literature.
    Tinmouth AT; Freedman J
    Transfus Med Rev; 2003 Jul; 17(3):181-93. PubMed ID: 12881779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.
    Wandt H; Frank M; Ehninger G; Schneider C; Brack N; Daoud A; Fackler-Schwalbe I; Fischer J; Gäckle R; Geer T; Harms P; Löffler B; Ohl S; Otremba B; Raab M; Schönrock-Nabulsi P; Strobel G; Winter R; Link H
    Blood; 1998 May; 91(10):3601-6. PubMed ID: 9572994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
    Wandt H; Schaefer-Eckart K; Wendelin K; Pilz B; Wilhelm M; Thalheimer M; Mahlknecht U; Ho A; Schaich M; Kramer M; Kaufmann M; Leimer L; Schwerdtfeger R; Conradi R; Dölken G; Klenner A; Hänel M; Herbst R; Junghanss C; Ehninger G;
    Lancet; 2012 Oct; 380(9850):1309-16. PubMed ID: 22877506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopenia and bleeding in pediatric oncology patients.
    Bercovitz RS; Josephson CD
    Hematology Am Soc Hematol Educ Program; 2012; 2012():499-505. PubMed ID: 23233625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
    Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
    Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding due to thrombocytopenia in acute leukemias and reevaluation of the prophylactic platelet transfusion policy.
    Aderka D; Praff G; Santo M; Weinberger A; Pinkhas J
    Am J Med Sci; 1986 Mar; 291(3):147-51. PubMed ID: 3456706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of platelet transfusion in patients with acute leukemia: an evaluation of methods.
    Apelseth TO; Bruserud O; Wentzel-Larsen T; Hervig T
    Transfusion; 2010 Apr; 50(4):766-75. PubMed ID: 20030789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet transfusion goals in oncology patients.
    Fasano RM; Josephson CD
    Hematology Am Soc Hematol Educ Program; 2015; 2015():462-70. PubMed ID: 26637759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients.
    Pisciotto PT; Benson K; Hume H; Glassman AB; Oberman H; Popovsky M; Hines D; Anderson K
    Transfusion; 1995 Jun; 35(6):498-502. PubMed ID: 7770901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-induced platelet reactivity correlates with bleeding in haemato-oncological patients.
    Batman B; van Bladel ER; van Hamersveld M; Pasker-de Jong PCM; Korporaal SJA; Urbanus RT; Roest M; Boven LA; Fijnheer R
    Vox Sang; 2017 Nov; 112(8):773-779. PubMed ID: 28960383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
    N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL.
    Heckman KD; Weiner GJ; Davis CS; Strauss RG; Jones MP; Burns CP
    J Clin Oncol; 1997 Mar; 15(3):1143-9. PubMed ID: 9060557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet transfusion in hematology, oncology and surgery.
    Wandt H; Schäfer-Eckart K; Greinacher A
    Dtsch Arztebl Int; 2014 Nov; 111(48):809-15. PubMed ID: 25512006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet Transfusion Practices in Critically Ill Children.
    Nellis ME; Karam O; Mauer E; Cushing MM; Davis PJ; Steiner ME; Tucci M; Stanworth SJ; Spinella PC;
    Crit Care Med; 2018 Aug; 46(8):1309-1317. PubMed ID: 29727368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit.
    Vamvakas EC; Hitzler WE
    Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.